Paper7684524
Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group.
Prostate, 1993. Cited by 140 papers, by iCite.
Cite this record
ConductScience Library. Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group. Papers, record 7684524. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7684524
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 5-alpha Reductase Inhibitors | Major topic |
| Androstenes | Major topic |
| Azasteroids | Major topic |
| Prostatic Hyperplasia | Major topic |
| Aged | |
| Aged, 80 and over | |
| Dihydrotestosterone | |
| Double-Blind Method | |
| Drug Tolerance | |
| Finasteride | |
| Humans | |
| Male | |
| Middle Aged | |
| Prostate | |
| Prostate-Specific Antigen | |
| Testosterone | |
| Ultrasonography | |
| Urination |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38243941 | Neurokinin B Administration Induces Dose Dependent Proliferation of Seminal Vesicles in Adult Rats. | Curr Protein Pept Sci | 2024 | https://conductscience.org/library/papers/38243941 | PubMed |
| 37994101 | Salvia miltiorrhiza Bunge Ameliorates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress via Nrf-2/HO-1 Activation. | J Microbiol Biotechnol | 2024 | https://conductscience.org/library/papers/37994101 | PubMed |
| 34747724 | Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis. | Asian J Androl | 2022 | https://conductscience.org/library/papers/34747724 | PubMed |
| 32314009 | The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis. | World J Urol | 2021 | https://conductscience.org/library/papers/32314009 | PubMed |
| 29531971 | BCL-2 and BCL-XL expression are down-regulated in benign prostate hyperplasia nodules and not affected by finasteride and/or celecoxib. | Am J Clin Exp Urol | 2018 | https://conductscience.org/library/papers/29531971 | PubMed |
| 28800482 | Targeting phenotypic heterogeneity in benign prostatic hyperplasia. | Differentiation | 2017 | https://conductscience.org/library/papers/28800482 | PubMed |
| 28795417 | Molecular pathogenesis of human prostate basal cell hyperplasia. | Prostate | 2017 | https://conductscience.org/library/papers/28795417 | PubMed |
| 27529214 | Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27529214 | PubMed |
| 26546040 | Isolation and analysis of discreet human prostate cellular populations. | Differentiation | 2016 | https://conductscience.org/library/papers/26546040 | PubMed |
| 26307022 | The many ways to make a luminal cell and a prostate cancer cell. | Endocr Relat Cancer | 2015 | https://conductscience.org/library/papers/26307022 | PubMed |
| 25032191 | Current role of treatment in men with lower urinary tract symptoms combined with overactive bladder. | Prostate Int | 2014 | https://conductscience.org/library/papers/25032191 | PubMed |
| 23570837 | Androgen receptor roles in the development of benign prostate hyperplasia. | Am J Pathol | 2013 | https://conductscience.org/library/papers/23570837 | PubMed |
| 21826125 | Medical treatment of benign prostatic hyperplasia. | Rev Urol | 2011 | https://conductscience.org/library/papers/21826125 | PubMed |
| 21031091 | The different reduction rate of prostate-specific antigen in dutasteride and finasteride. | Korean J Urol | 2010 | https://conductscience.org/library/papers/21031091 | PubMed |
| 20927745 | Finasteride for benign prostatic hyperplasia. | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20927745 | PubMed |
| 20126609 | Pathophysiology of benign prostatic hyperplasia: insights from medical therapy for the disease. | Rev Urol | 2009 | https://conductscience.org/library/papers/20126609 | PubMed |
| 19756467 | [Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)]. | Urologe A | 2009 | https://conductscience.org/library/papers/19756467 | PubMed |
| 19707263 | Finasteride in the treatment of patients with benign prostatic hyperplasia: a review. | Ther Clin Risk Manag | 2009 | https://conductscience.org/library/papers/19707263 | PubMed |
| 19296071 | [Treatment of LUTS in BPS. When and when not to administer pills?]. | Urologe A | 2009 | https://conductscience.org/library/papers/19296071 | PubMed |
| 19252137 | Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19252137 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7684524
GET https://conductscience.org/api/papers/v1/7684524/cited_by?page=2